#431: Meet Alex Naber: Insider Insights on Quality Systems, Design Quality, and MedTech's Patient-First Ethos

Global Medical Device Podcast · 3 Nov 2025 · 26m · Episode 431

What this episode covers

Alex Naber, a medical device consultant at Greenlight Guru, discusses his career path from bioengineering to design quality and post-market management at Zimmer Biomet. He explains how Greenlight Guru's eQMS and EDC solutions eliminate the pain points of fragmented, spreadsheet-based design controls by building true, linked traceability directly into the system. Naber also highlights the value of pre-built QMS templates that accelerate implementation for small-to-midsize companies, avoiding the 'bloated' procedures typical of large corporations. Finally, he addresses the upcoming QMSR transition, reassuring listeners that compliance is manageable for those already adhering to ISO 13485.

Other shows on the same ground, closest first.

  • Being an Engineer · 37m

    S1E12 Simplifying Quality Management | Jon Speer

    Jon Speer, founder of Greenlight Guru, explains how his frustration with managing medical device quality via Excel spreadsheets led to the creation of a dedicated QMS software platform. He details the transition from chemical engineering to medical device systems, highlighting the specific pain points of manual data merging and the high validation burden for electronic records. The episode covers Greenlight Guru’s development, its focus on design controls and traceability matrices, and the regulatory challenges of FDA submissions and ISO 13485 certification for startups.

  • Being an Engineer · 51m

    S5E29 Steve Gompertz | Medical Device Quality Control & Regulatory Requirements

    Steve Gompertz, a partner at QRx Partners with prior leadership roles at Medtronic, Boston Scientific, St. Jude Medical, and Pelican Biothermal, explains how to build scalable quality management systems for medical device companies. He details the evolution of regulatory frameworks, noting the shift toward stricter EU standards and the integration of AI and cybersecurity into device compliance. Gompertz emphasizes tailoring quality systems to company size, using a case study of a client who reduced FDA findings from dozens to zero by implementing a holistic, process-connected system rather than a checklist approach. He also advocates for concurrent engineering and cross-functional teams to accelerate development while maintaining rigorous safety standards.

  • Let's Combinate · 48m

    127 - BIG Risk Management Changes in QMSR, Risk Acceptability, Risk Policy & Explaining vs. Justifying Risk Decisions with Naveen Aggarwal

    Naveen Aggarwal, founder of Creative Analytic Solutions, explains that the QMSR final rule does not mandate ISO 14971 but requires risk management to be integrated into ISO 13485 quality systems, shifting FDA inspection focus from procedural compliance to risk-based decision-making. He highlights that small and mid-size companies face significant costs to transition, while large firms must overcome the challenge of linking risk outputs to design inputs and post-market data. Aggarwal advises against standalone risk policies, suggesting instead that companies integrate risk acceptability criteria into their existing quality policies and use clear, binary (red/green) risk matrices rather than ambiguous yellow zones.

  • Let's Combinate · 32m

    130 - QMSR Changes to Traceability/Reporting, Independent Reviewer & Risk Management, Learning New Regulations and MDSAP with Aaron Snyder

    Aaron Snyder, VP of Quality Assurance at Allotex and AAMI Faculty member, explains the FDA's Quality Management System Regulation (QMSR) and its incorporation of ISO 13485. He details specific changes to traceability, including the requirement to meet 21 CFR Part 821 (Medical Device Tracking) and Part 830 (UDI) in addition to ISO requirements, and new FDA-specific controls for records, packaging, and labeling. Snyder contrasts FDA inspection techniques, which focus on finding non-compliance through deep dives into complaint and service records, with ISO surveillance audits that verify conformity. He also discusses the impact of QMSR on MDSAP companies, noting that while harmonization simplifies compliance for large firms, smaller US-only companies face more work to adopt the process approach and explicit risk management.

  • Let's Combinate · 30m

    100 - PQMCoach, Our First Recording, Quality (Big Q/little q), Why Predictive Quality Management, and Communicating Quality with Larry Mager

    Larry Mager, Principal at Mgmt-Ctrl and founder of PQMCoach.com, discusses his evolution from a Fortune 500 quality engineer to a startup operator who built a Quality Management System (QMS) from scratch for a cardiovascular device. He explains the shift from 'Big Q' compliance to 'Little Q' operational excellence, detailing how he navigated an FDA consent decree at a large manufacturer and later moved into consulting to address communication barriers in quality management. Mager advocates for Predictive Quality Management (PQM) and the Plan-Do-Check-Act (PDCA) cycle as universal tools for improving business performance across pharma, medical devices, and CROs.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by Global Medical Device Podcast. The episode itself belongs to its publisher.